Freeline Therapeutics
Thangavelu Kaliyappan, PhD, is a seasoned scientist currently serving as a Senior Scientist at Freeline since June 2022. Prior to this role, Kaliyappan held the position of Postdoctoral Research Scientist at The Institute of Cancer Research from 2017 to May 2022 and worked as a Postdoctoral Researcher at The Netherlands Cancer Institute from 2012 to 2016. Kaliyappan earned a Doctor of Philosophy (PhD) from the National University of Singapore in 2012, an M.Tech in Biotechnology from Anna University Chennai in 2007, and a B.Pharm in Pharmaceutical Sciences from Tamil Nadu Doctor M.G.R. Medical University in 2004.
This person is not in any offices
Freeline Therapeutics
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.